S7 higher scores for chronic inflammation compared to those with dupA-negative strains (2.36 vs. 2.24, p = 0.058). The presence of dupA was not associated with the cagA, vacA, iceA or babA 2 genotypes. Conclusions: In Shanghai the prevalence of dupA gene was highest in DU and inversely related to GU and gastric cancer both which are associated with corpus atrophy.
In order to categorise a bacterium as sensitive to an antibiotic, it is necessary to perform a phenotypic antimicrobial susceptibility test. Phenotypic AST systems need breakpoints to. categorise bacteria S, I or R. Breakpoints are best determined by breakpoint committees consisting of experts in the fields of clinical microbiology and infectious diseases. Both CLSI (formerly NCCLS in the USA) and EUCAST (the European Committee on Antimicrobial Susceptibility Testing) are well known breakpoint committees. The former is a commercial enterprise engaging the pharmaceutical industry and the profession whereas the EUCAST is organised by the European Centre for Disease Control, the European Medicines Evaluation Agency and the European Society for Clinical Microbiology and Infectious Diseases. EUCAST has harmonised breakpoints for Europe and acts as the EMEA breakpoint committee during the process of approval of new drugs. EUCAST breakpoints are currently being introduced in automated systems for AST. The Phoenix from Becton Dickinson is already validated with EUCAST breakpoints and the Vitek2 from BioMerieux is to follow. A disk test based on Mueller Hinton agar and 108 cfu/mL inoculum is currently being developed by EUCAST. New therapeutic traditions, dosage practices, new tools for setting breakpoints and most importantly new resistance mechanisms necessitates an evolutionary process for clinical breakpoints. EUCAST has an active process for reviewing and revising breakpoints. EUCAST offers free documents on breakpoints, methods and interpretive criteria on its website (www.eucast.org) which also displays MIC-(and eventually zone diameter-) distributions of wild type bacteria on the website. These can be used for calibration of methods.
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Laribacter hongkongensis: From discovery to complete genome sequence P.C.Y. Woo.
Department of Microbiology, The University of Hong Kong, Hong Kong, China
Despite extensive investigations, a microbiological cause cannot be found in about half of the patients with infectious disease. Throughout the years, scientists have spent tremendous efforts in looking for microorganisms associated with these "unexplained infectious disease syndromes". In 2001, we discovered Laribacter hongkongensis gen. nov. sp. nov., a facultative anaerobic, Gram-negative, S-shaped, urease-positive rod of the Neisseriaceae family, from blood and empyema thoracis of a patient with alcoholic cirrhosis. During the past seven years, we have documented that L. hongkongensis was associated with gastroenteritis and traveler's diarrhea and cases were found globally in patients who resided in or had recent travel histories to countries in Asia, Europe, America and Africa. We have found that freshwater fish is the reservoir and it was also found in drinking water reservoirs. We have cloned the beta-lactamase and tetracycline resistance genes and developed gene deletion and expression systems for L. hongkongensis. Due to the potential of its clinical importance and related ecology, important phenotypic characteristics and phylogenetic position, and the availability of genetic manipulation systems for downstream experiments, we sequenced the complete genome of L. hongkongensis, with the aim of achieving better understanding of its biology, mechanism of adaptation to different hosts, and virulence mechanisms.
I-19 Antibiotic resistance in gram-negative pathogens:
Dealing with untreatable infections P.A. Tambyah *. National University of Singapore, Singapore
While resistant gram-positive pathogens such as MRSA and VRE have received a lot of attention especially in the US and Europe, there have been rising numbers of multi-resistant and even pan-drug resistant strains of gram-negative bacilli in particular Pseudomonas and Acinetobacter spp. These have posed tremendous challenges to the clinicians looking after patients especially in Asia and Southern Europe. With limited therapeutic options, a greater focus on prevention and control has resulted. We are also hampered by a lack of good data to explain the emergence of these pathogens and to understand the reasons for their spread to our vulnerable patients. Streptococcus suis infections are enzootic in pigs where sporadic cases occur in humans. Since the first human case was recorded in 1968, only 250 cases have been reported globally through June 2005. The majority of the cases have resulted in meningitis often associated with hearing loss. During the period from July to August 2005, however, an explosive outbreak of 215 cases of human infection occurred in Sichuan Province, China. Sixty-one of the 215 (28%) patients presented an unusual streptococcal toxic shock like syndrome (STSLS) with high mortality (38 of 61; 62%) in previously healthy farmers. Both the clinical presentation and epidemiology features of the Sichuan outbreak had not previously been observed. This outbreak was caused by a mutant S. suis named as sequence type 7 (ST7) using the multi-locus sequence typing method, the method of choice for addressing questions related to genotyping for epidemiological studies, population, and evolutionary biology. The ST7 strain caused a single case described from Hong Kong in 1996; then it emerged to cause a small outbreak in Jiangsu in 1998; and spread to cause the largest ever outbreak with severe shock in 2005. It was found that the serum levels of IL-1b, IL-6, IL-8, IL-12, p70, IFN-g and TNF-a, the inflammation cytokines, during the early phase of the disease were significantly elevated in patients with STSLS compared to those with meningitis only. And, the serum levels of pro-inflammatory cytokines were significantly higher in mice infected with the ST7 strain than in those infected with either the ST1 or ST25 strains. Genome comparisons showed the ST1 strain had acquired 132 genomic islands, including 5 pathogenicity islands, and the "epidemic" strain ST7 had acquired an additional 5 genomic islands. Therefore, We proposed the intermediate virulent ST25 type evolved to become the highly pathogenic
